Search

Your search keyword '"Morrow, Christopher"' showing total 383 results

Search Constraints

Start Over You searched for: Author "Morrow, Christopher" Remove constraint Author: "Morrow, Christopher"
383 results on '"Morrow, Christopher"'

Search Results

102. Abstract A107: Small Molecule Degraders of the Estrogen Receptor (SERDs): Optimization of the tricyclic indole scaffold beyond AZD9496

103. Conformational analysis of cyclic tetrapeptides by global energy minimisation calculations

104. Metabolism in the Midwest: research from the Midwest Aging Consortium at the 49th Annual Meeting of the American Aging Association.

105. Donor-initiated common pool resource institutions: the case of the Yanesha Forestry Cooperative

106. Growth management in the city of San Diego: planning the future now

107. Building Bridges in a Series of Estrogen Receptor Degraders: An Application of Metathesis in Medicinal Chemistry

111. Tricyclic Indazoles—A Novel Class of Selective Estrogen Receptor Degrader Antagonists

113. The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer

115. Metabolism in the Midwest: research from the Midwest Aging Consortium at the 49thAnnual Meeting of the American Aging Association

117. Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists

118. Depression and suicidality in an Afghan refugee: A case report.

119. Tricyclic IndazolesA Novel Class of Selective Estrogen Receptor Degrader Antagonists.

120. Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

121. BMX Acts Downstream of PI3K to Promote Colorectal Cancer Cell Survival and Pathway Inhibition Sensitizes to the BH3 Mimetic ABT-73712

122. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

126. Abstract PL04-04: Developing circulating tumor cell derived explant models (CDX)

127. Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

131. Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 phase 2 trial.

132. Development of a circulating miRNA assay to monitor tumor burden: From mouse to man

136. Abstract 3060: Circulating tumor cells from small cell lung cancer patients are tumorigenic

137. Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer

139. Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia

140. Stretch Forming Studies on Thermoplastic Composite

141. Hyperorality in Frontotemporal dementia: Cognitive, Behavioral, and Neuroanatomic Profiles in Early‐Stage Disease.

143. [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941

147. Activation energy for the hydrogenation of iron in p-type crystalline silicon wafers

Catalog

Books, media, physical & digital resources